Hua Medicine Ltd.
0.30
USD
+0.01
(+3.44%)
Important Dates
Hua Medicine's next confirmed earnings release is scheduled for April 1, 2027.
| Earnings Date | 4/1/2027 |
Share Statistics
As of December 31, 2025, Hua Medicine has 996.52M shares outstanding.
| Shares Outstanding | 996.52M |
Financial Position
As of December 31, 2025, Hua Medicine maintains a current ratio of 6.17, meaning it holds 6.2x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 6.17 |
| Quick Ratio | 5.19 |
| Debt / Equity | 29.97 |
Financial Efficiency
These figures cover the twelve months ended December 31, 2025.
| Employee Count | 248.00 |
Stock Price Statistics
As of the close on October 6, 2026, Hua Medicine's stock has declined approximately 26.08% over the past 52 weeks.
| 52-Week Price Change | -26.08% |
Balance Sheet
USDAs of December 31, 2025, Hua Medicine holds 156.21M in cash and equivalents against 43.14M in total debt, resulting in a net debt position of -120.29M. Total book value stands at 143.93M, with working capital of 155.33M providing operational flexibility.
| Cash & Cash Equivalents | 156.21M |
| Total Debt | 43.14M |
| Net Debt | -120.29M |
| Equity (Book Value) | 143.93M |
| Book Value Per Share | 0.14 |
| Working Capital | 155.33M |